New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 10, 2014
07:39 EDTSKXSkechers should be an outperformer in Q1, says Brean Capital
Brean Capital said Skechers should be an outperformer in Q1 despite the weather and traffic issues. The firm cited its well rounded assortment across all categories, increased international exposure, and deeper e-commerce penetration. Shares are Buy rated with a $50 price target.
News For SKX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2014
12:31 EDTSKXSkechers pullback brings 'optimal' entry point, says Wunderlich
Subscribe for More Information
12:17 EDTSKXOn The Fly: Midday Wrap
Subscribe for More Information
11:22 EDTSKXSkechers rebounds after refuting Barrington research report
Subscribe for More Information
09:05 EDTSKXSkechers remains a top pick at Sterne Agee
Sterne Agee said Skechers (SKX) business remains robust and outlook promising despite the noise in the shares yesterday and reiterates it as a top pick.
09:01 EDTSKXSkechers says Q3 bookings up more than 50% from last year
Skechers COO and CFO David Weinberg, as part of his rebuttal to research published yesterday by Buckingham Research Group, stated that, “With a deeper dive and channel checks conducted which is always recommended, the results would be more conclusive. As indicated by SportScan and our retail partners, we are continuing to take market share. We have seen only one material decrease in our kids business in one account in the South due to a significant planned decrease in the number of doors, though our business in the existing doors remains strong. This is already the biggest booking third quarter in the history of the Company with an over 50% increase from third quarter of last year, and the SKECHERS retail stores continue to show positive comp store increases on top of significant retail store comp increases last year. Given channel checks, SKECHERS retail performance, our incoming order rate which leads us to an increased backlog worldwide, we remain confident that our domestic and international business is strong, that our brand continues to be in demand, and that our product and marketing resonate with consumers around the world.”
08:49 EDTSKXSkechers comments on Buckingham research,says SportScan data can be skewed
Subscribe for More Information
September 24, 2014
16:22 EDTSKXOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a report showed that sales of new homes rose to their highest level in over six years in August. The volume and news flow were relatively light, which may be the case again tomorrow as many market participants celebrate the Jewish holiday of Rosh Hashanah. ECONOMIC EVENTS: In the U.S., new home sales rose 18.0% in August to a 504K unit rate, which was much higher than the expected 4.4% increase. COMPANY NEWS: Bed Bath & Beyond (BBBY) advanced $4.64, or 7.4%, to $67.33 after the home goods retailer last night reported second quarter earnings and revenue that surpassed analysts' consensus estimates. The better than expected report and rise in the stock comes a day after William Blair downgraded the stock yesterday morning... Citizen Financial (CFG), the U.S. retail bank unit of Royal Bank of Scotland (RBS), became the year's second largest IPO behind Alibaba (BABA) after 140M shares began trading on the NYSE this morning. The stock ended it first day up $1.58, or 7.35%, at $23.08, which was far cry from the advance seen by another of the day's new stock debuts. CyberArk (CYBR) priced 5.36M shares at $16.00, opened for trade at $25.00 and ended the day at $29.94, making for a rise of over 87% from its IPO pricing. MAJOR MOVERS: Among the notable gainers was Acorda Therapeutics (ACOR), which advanced $8.27, or 28.18%, to $37.62 after the company agreed to acquire Civitas Therapeutics for $525M in cash. Civitas, which was private, had been scheduled to come public via an IPO that was expected to happen later this week prior to the deal announcement. Also higher was Hasbro (HAS), which rose $2.01, or 3.8%, to $54.95 after striking a deal that gives the company global rights, excluding Japan, to develop dolls based on Disney's (DIS) princess characters, as well as Frozen, beginning in 2016. Mattel (MAT), which currently holds those rights, slid 40c, or 1.25%, to $31.67 in the wake of the news. Also lower were shares of Skechers (SKX), which fell $5.69, or 9.8%, to $52.40 after research firm SportscanInfo reported that the footwear maker's sales had fallen 3% last week. However, Sterne Agee recommended buying the stock on the weakness. INDEXES: The Dow rose 154.19, or 0.9%, to 17,210.06, the Nasdaq gained 46.53, or 1.03%, to 4,555.22, and the S&P 500 added 15.53, or 0.78%, to 1,998.30.
10:44 EDTSKXSkechers falls after Sportscan says sales down 3% last week
Subscribe for More Information
10:15 EDTSKXSkechers weakness a buying opportunity, says Sterne Agee
Subscribe for More Information
10:11 EDTSKXSkechers lower after Buckingham comments on sales data
Subscribe for More Information
10:09 EDTSKXSkechers weakness a buying opportunity, says Sterne Agee
September 18, 2014
09:22 EDTSKXBack to school season healthy for footwear, says Sterne Agee
Subscribe for More Information
September 17, 2014
12:46 EDTSKXSkechers pullback a buying opportunity, says Wunderlich
Subscribe for More Information
12:43 EDTSKXSkechers reiterated Buy at Wunderlich
Subscribe for More Information
11:16 EDTSKXOptions with increasing implied volatility:
Options with increasing implied volatility: WB SDRL TAP AGNC IYR SKX
09:01 EDTSKXSkechers files infringement lawsuit against DB Shoe Company
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use